Abstract 5159: Characterization of a novel class of RAS inhibitory compounds with potent anti-tumor activity
Antonio Ward(USA Mitchell Cancer Institute), Adam B. Keeton(Washburn University), Tyler Mattox(USA Mitchell Cancer Institute), Ashley S. Lindsey(USA Mitchell Cancer Institute), Kevin J. Lee(University of Alabama at Birmingham), Gary A. Piazza(Auburn University), Kate McConnell(USA Mitchell Cancer Institute), Kristy Berry(USA Mitchell Cancer Institute), Xi Chen(First Affiliated Hospital of Xiamen University), Bing Zhu(China University of Geosciences (Beijing)), Verónica Ramírez‐Alcántara(USA Mitchell Cancer Institute), Jacob Valiyaveettil(USA Mitchell Cancer Institute), Michael R. Boyd(Chatham University)
Cited by 0
Related Papers
Ligand steric properties
|Coordination Chemistry Reviews|1993|210
Cardiac Troponin I Gene Knockout
|Circulation Research|1999|157
Michellamines D−F, New HIV-Inhibitory Dimeric Naphthylisoquinoline Alkaloids, and Korupensamine E, a New Antimalarial Monomer, from <i>Ancistrocladus korupensis</i>
|Journal of Natural Products|1997|97
siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy
|International Journal of Nanomedicine|2018|74
A molecular mechanics model of ligand effects. 2. Binding of phosphines to pentacarbonylchromium
|Inorganic Chemistry|1992|67